On Thursday, Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) announced that it had signed an LOI to sell its digital technology subsidiary, Mindleap Health Inc., to PanGenomic Health Inc. The deal is valued at C$4 million. “We are extremely pleased with what we have accomplished with Mindleap Health,” said Josh Bartch, CEO and Chairman of Mydecine. “We […]
